Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Inclusion Criteria: * clinical diagnosis of ITP * platelet count of \<50 X 10\^9 Exclusion Criteria: * planned splenectomy * previous non-responders to IVIg treatment * known or suspected hypersensitivity or previous evidence of severe side effects to immunoglobulin therapy * patients who have received treatment with: 1. IVIg or anti-D immunoglobulin 2. immunosuppressive, any other immunomodulatory drug(s) or other active treatment(s)for ITP within three weeks prior to first day of study drug administration 3. patients who have received IV administration of steroids OR have had a change of oral corticosteroid treatment OR danazol within 15 days prior to first day of study drug administration.